Products for Research Use Only
RegisterLogin

Praluzatamab ravtansine

CAT: 0957-D4039-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-D4039-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAb conjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation.
CAS Number
2145115-85-9
Synonyms
CX-2009
Target
CD markers
Activity
Transmembrane Transporters
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Related Products

CatalogName
D4026-01Tusamitamab ravtansine
D4026-1mg*5Tusamitamab ravtansine
D4011-01Anetumab ravtansine
D4032-01Cantuzumab ravtansine
D4032-1mg*5Cantuzumab ravtansine
D4032-1mgCantuzumab ravtansine
D4026-1mgTusamitamab ravtansine
D4011-1mg*5Anetumab ravtansine
D4011-1mgAnetumab ravtansine
A2592-1mg*5Praluzatamab (Anti-ALCAM / CD166)

Alternative Products

CatalogName
T9901A-034-01Praluzatamab ravtansine
MBS1581548-01Praluzatamab ravtansine (ADC)
GTR18401353-01Praluzatamab ravtansine Antibody
ICH5785R-1mgPraluzatamab Ravtansine Biosimilar - Research Grade
F1127-5Anti-ALCAM/CD166 Antibody (Praluzatamab ravtansine)
GTR18315791ALCAM/CD166 Reference Antibody (praluzatamab ravtansine)
BIO0883SM-1mgAnti-human ALCAM/CD166 (Praluzatamab ravtansine Biosimilar)
E24CHB273Anti-ALCAM/CD166 Reference Antibody (Praluzatamab ravtansine)
HY-P99788-01Praluzatamab
413861Ravtansine

Popular Products